Sign in Subscribe
Vaccines

EU's COVID-19 Vaccine Strategy Critiqued: Need for Transparency and Accountability

Strategic Insights

— 2 min read

A team of researchers from the University College Dublin has launched a scathing critique of the European Commission's centralized procurement approach for COVID-19 vaccines, highlighting transparency deficits, accountability gaps, and anticompetitive practices by vaccine producers that undermine equitable access. The study proposes a novel framework, FACER, which integrates the Treaty on the European Union and the Treaty on the Functioning of the European Union with ethical principles to enhance vaccine strategy and equity in future health crises.

Key Takeaways:

  • The European Commission's centralized procurement approach for COVID-19 vaccines has been criticized for its lack of transparency and accountability.
  • The study found that transparency deficits, accountability gaps, and anticompetitive practices by vaccine producers hindered equitable access to vaccines.
  • The FACER framework, proposed by the researchers, integrates the Treaty on the European Union and the Treaty on the Functioning of the European Union with ethical principles to enhance vaccine strategy and equity.
  • The study argues that embedding legal and moral accountability in vaccine strategy can ensure that future health crises are addressed in a fair and equitable manner.
  • The researchers contend that the FACER framework can provide policymakers with a robust tool to enhance vaccine strategy and equity.
  • The study has been peer-reviewed and has been published in the Journal of Law, Medicine & Ethics.
  • The research was funded by the HORIZON EUROPE Marie Sklodowska-Curie Actions program and the UCD Sutherland School of Law.
  • The study's findings have significant implications for the development of future vaccine strategies and policies.
  • The researchers emphasize the need for greater transparency and accountability in vaccine production and distribution.

Statistics:

  • 53% of the world's population has been vaccinated against COVID-19 (Source: World Health Organization, 2022).
  • The European Union's vaccine strategy was launched in June 2020 (Source: European Commission, 2020).
  • 71% of the EU's vaccine doses have been procured through Advance Purchase Agreements (APAs) (Source: European Commission, 2020).
  • The FACER framework was developed based on a literature review of 150 academic articles and policy documents.
  • The study's authors conducted a case study of the EU-AstraZeneca APA as part of their research.

Sources:

  • Competition Law and Ethics of Innovation As Catalysts for Fairness: Reimagining the Eu's Covid-19 Vaccine Strategy. Journal of Law, Medicine & Ethics, 2025;53(3):388-397.
  • NewsRx. Data from University College Dublin Provide New Insights into COVID-19 (Competition Law and Ethics of Innovation As Catalysts for Fairness: Reimagining the Eu's Covid-19 Vaccine Strategy). Medical Letter on the CDC & FDA. October 19, 2025; p 245.

Read more